The Institute's mission is to provide objective educational programmes, symposia and supportive tools developed in cooperation with the faculty, other opinion leaders and healthcare providers in order to improve the quality of life of patients suffering from CNS diseases.

In order to accomplish this, the Lundbeck Institute provides an international forum in which:

• New scientific issues and practical clinical experience are discussed and ideas exchanged.
• Consensus in relation to improved care will be secured through the organization of informal, interactive seminars in which participants include distinguished international experts.
• Customized materials are distributed for local implementation.
  

At the outset, the focus of the Institute is on schizophrenia and mood disorders. Other psychiatric and neurological illnesses, such as anxiety and Parkinsonism, will be added to its areas of study later.

The Institute's activities are controlled by the Lundbeck International Neuroscience Foundation, which is an independent legal entity. Thus, the activities are fully dedicated to non-product related activities, and there will never be advertising in favour of drugs from any medical company. Both organizations observe the standards laid down by the Accreditation Council for Continuing Medical Education and will follow the European Accreditation Guidelines which are currently under development.

The Lundbeck International Neuroscience Foundation and Lundbeck Institute initiatives are supported by many of the major international psychiatric organizations, including:

WPA - World Psychiatric Association

AEP - Association of European Psychiatrists

ECNP - European College of Neuropsychopharmacology

CINP - Collegium Internationale Neuro-Psychopharmacologicum